ArticleFuture oncology (London, England)2024

Adjuvant chemoradiotherapy plus PD-1 inhibitor for pN3 gastric cancer: a randomized, multicenter, Phase III trial.

Wang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.